4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-20-043010
Chief Scientific Officer sold 33,300 shares at an average $39.58 ($1,317,980)
- Chief Scientific Officer acquired 33,300 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ROBINS HARLAN S Chief Scientific Officer | 2020-07-16 | Option exercise | +22,200 | $6.32 | $140,304 | 22,879 | D: show line 1 in the form |
| ROBINS HARLAN S Chief Scientific Officer | 2020-07-16 | Sale | −14,820 | $39.39 | $583,760 | 8,059 | D: show line 2 in the form |
| ROBINS HARLAN S Chief Scientific Officer | 2020-07-16 | Sale | −7,380 | $39.92 | $294,610 | 679 | D: show line 3 in the form |
| ROBINS HARLAN S Chief Scientific Officer | 2020-07-17 | Option exercise | +11,100 | $6.32 | $70,152 | 11,779 | D: show line 4 in the form |
| ROBINS HARLAN S Chief Scientific Officer | 2020-07-17 | Sale | −1,200 | $38.61 | $46,332 | 10,579 | D: show line 5 in the form |
| ROBINS HARLAN S Chief Scientific Officer | 2020-07-17 | Sale | −8,194 | $39.62 | $324,646 | 2,385 | D: show line 6 in the form |
| ROBINS HARLAN S Chief Scientific Officer | 2020-07-17 | Sale | −1,706 | $40.23 | $68,632 | 679 | D: show line 7 in the form |
| Open-market sales · 33,300 sh · avg $39.58 · $1,317,980 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ROBINS HARLAN S Chief Scientific Officer | 2020-07-16 | Option exercise · Stock Option (Right to Buy) | −22,200 | 378,000 | D: show line 8 in the form | ||
| ROBINS HARLAN S Chief Scientific Officer | 2020-07-17 | Option exercise · Stock Option (Right to Buy) | −11,100 | 366,900 | D: show line 9 in the form |
Loading xslF345X03/doc4.xml…